Effects of green tea extract on lung cancer A549 cells: Proteomic identification of proteins associated with cell migration

Proteomics

Volumn 9, Issue 3, 2009, Pages 757-767

  Lu, Qing Yi ^a   Yang, Yanan ^b,e   Jin, Yu Sheng ^a   Zhang, Zuo Feng ^c   Heber, David ^a   Li, Frederick P ^d   Dubinett, Steven M ^a   Sondej, Melissa A ^b   Loo, Joseph A ^a,b   Rao, Jian Yu ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e AGILENT TECHNOLOGIES   (United States)

Author keywords

Green tea; Human lung adenocarcinoma cells; Lamins A C; Proteomics

Indexed keywords

ACTIN; GREEN TEA EXTRACT; LAMIN A; LAMIN C; SMALL INTERFERING RNA;

AMINO ACID SEQUENCE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CALCIUM BINDING; CELL ADHESION; CELL METABOLISM; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HUMAN; HUMAN CELL; LUNG CANCER; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS;

CELL LINE, TUMOR; CELL MOVEMENT; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOBLOTTING; IN SITU NICK-END LABELING; LUNG NEOPLASMS; PLANT EXTRACTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TEA;

EID: 60549105394     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200800019     Document Type: Article

References (51)

1. Lambert, J. D., Yang, C. S., Cancer chemopreventive activity and bioavailability of tea and tea polyphenols. Mutat. Res. 2003, 523, 201-208.
2. Khan, N., Afaq, F., Saleem, M., Ahmad, N. et al., Targeting multiple signaling pathways by green tea polyphenol (-)- epigallocatechin-3- gallate. Cancer Res. 2006, 66, 2500-2505.
3. Lu, Q. Y., Jin, Y. S., Pantuck, A., Zhang, Z. F. et al., Green tea extract modulates actin remodeling via Rho activity in an in vitro multistep carcinogenic model. Clin. Cancer Res. 2005, 11, 1675-1683.
4. Xiao, G. S., Jin, Y. S., Lu, Q. Y., Zhang, Z. F. et al., Annexin-I as a potential target for green tea extract induced actin remodeling. Int. J. Cancer 2006, 120, 111-120.
5. Lu, Q. Y., Jin, Y. S., Zhang, Z. F., Le, A. D. et al., Green tea induces annexin-I expression in human lung adenocarci-noma A549 cells: Involvement of annexin-I in actin remodeling. Lab. Invest. 2007, 87, 456-465.
6. Kweon, M. H., Adhami, V. M., Lee, J. S., Mukhtar, H., Constitutive overexpression of Nrf2-dependent heme oxygenase-1 in A549 cells contributes to resistance to apoptosis induced by epigallocatechin 3-gallate. J. Biol. Chem. 2006, 281, 33761-33772.
7. Henning, S. M., Niu, Y., Lee, N. H., Thames, G. D. et al., Bioavailability and antioxidant activity of tea flavanols after consumption of green tea, black tea, or a green tea extract supplement. Am. J. Clin. Nutr. 2004, 80, 1558-1564.
8. Chow, H. H., Cai, Y., Hakim, I. A., Crowell, J. A. et al., Phar-acokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals. Clin. Cancer Res. 2003, 9, 3312-3319.
9. Ullmann, U., Haller, J., Decourt, J. P., Girault, N. et al., A single ascending dose study of epigallocatechin gallate in healthy volunteers. J. Int. Med. Res. 2003, 31, 88-101.
10. Yang, C. S., Chen, L., Lee, M. J., Balentine, D. et al., Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Cancer Epidemiol. Biomarkers Prev. 1998, 7, 351-354.
11. Chow, H. H., Hakim, I. A., Vining, D. R., Crowell, J. A. et al., Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals. Clin. Cancer Res. 2005, 11, 4627-4633.
12. Suganuma, M., Okabe, S., Oniyama, M., Tada, Y. et al., Wide distribution of [3H] (-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue. Carcinogenesis 1998, 19, 1771-1776.
13. Kaufmann, S. H., Mabry, M., Jasti, R., Shaper, J. H., Differential expression of nuclear envelope lamins A and C in human lung cancer cell lines. Cancer Res. 1991, 51, 581-586.
14. Broers, J. L., Raymond, Y., Rot, M. K., Kuijpers, H. et al., Nuclear A-type lamins are differentially expressed in human lung cancer subtypes. Am. J. Pathol. 1993, 143, 211-220.
15. Dragnev, K. H., Stover, D., Dmitrovsky, E., Lung cancer prevention: The guidelines. Chest 2003, 123, 60S-71S.
16. Hutchison, C. J., Worman, H. J., A-type lamins: Guardians of the soma? Nat. Cell Biol. 2004, 6, 1062-1067.
17. Lammerding, J., Schulze, P. C., Takahashi, T., Kozlov, S. et al., Lamin A/C deficiency causes defective nuclear mechanics and mechanotransduction. J. Clin. Invest. 2004, 113, 370-378.
18. Lammerding, J., Fong, L. G., Ji, J. Y., Reue, K. et al., Lamins A and C but not lamin B1 regulate nuclear mechanics. J. Biol. Chem. 2006, 281, 25768-25780.
19. Caille, N., Thoumine, O., Tardy, Y., Meister, J. J., Contribution of the nucleus to the mechanical properties of endothelial cells. J. Biomech. 2002, 35, 177-187.
20. Guilak, F., Tedrow, J. R., Burgkart, R., Viscoelastic properties of the cell nucleus. Biochem. Biophys. Res. Commun. 2000, 269, 781-786.
21. Broers, J. L., Peeters, E. A., Kuijpers, H. J., Endert, J. et al., Decreased mechanical stiffness in LMNA-/-cells is caused by defective nucleo-cytoskeletal integrity: Implications for the development of laminopathies. Hum. Mol. Genet. 2004, 13, 2567-2580.
22. Pajerowski, J. D., Dahl, K. N., Zhong, F. L., Sammak, P. J. et al., Physical plasticity of the nucleus in stem cell differentiation. Proc. Natl. Acad. Sci. USA 2007, 104, 15619-15624.
23. Zaman, M. H., Trapani, L. M., Sieminski, A. L., Mackellar, D. et al., Migration of tumor cells in 3D matrices is governed by matrix stiffness along with cell-matrix adhesion and proteolysis. Proc. Natl. Acad. Sci. USA 2006, 103, 10889-10894.
24. Kole, T. P., Tseng, Y., Jiang, I., Katz, J. L. et al., Intracellular mechanics of migrating fibroblasts. Mol. Biol. Cell 2005, 16, 328-338.
25. Nagayama, M., Haga, H., Kawabata, K., Drastic change of local stiffness distribution correlating to cell migration in living fibroblasts. Cell Motil. Cytoskeleton 2001, 50, 173-179.
26. Bereiter-Hahn, J., Luers, H., Subcellular tension fields and mechanical resistance of the lamella front related to the direction of locomotion. Cell Biochem. Biophys. 1998, 29, 243-262.
27. Wang, N., Mechanical interactions among cytoskeletal filaments. Hypertension 1998, 32, 162-165.
28. Kidoaki, S., Matsuda, T., Shape-engineered fibroblasts: Cell elasticity and actin cytoskeletal features characterized by fluorescence and atomic force microscopy. J. Biomed. Mater. Res. A 2007, 81, 803-810.
29. Chaudhuri, O., Parekh, S. H., Fletcher, D. A., Reversible stress softening of actin networks. Nature 2007, 445, 295-298.
30. Park, S., Koch, D., Cardenas, R., Kas, J. et al., Cell motility and local viscoelasticity of fibroblasts. Biophys. J. 2005, 89, 4330-4342.
31. Mahaffy, R. E., Park, S., Gerde, E., Kas, J. et al., Quantitative analysis of the viscoelastic properties of thin regions of fibroblasts using atomic force microscopy. Biophys. J. 2004, 86, 1777-1793.
32. Broers, J. L., Machiels, B. M., Kuijpers, H. J., Smedts, F. et al., A-and B-type lamins are differentially expressed in normal human tissues. Histochem. Cell Biol. 1997, 107, 505-517.
33. Rober, R. A., Weber, K., Osborn, M., Differential timing of nuclear lamin A/C expression in the various organs of the mouse embryo and the young animal: A developmental study. Development 1989, 105, 365-378.
34. Stadelmann, B., Khandjian, E., Hirt, A., Luthy, A. et al., Repression of nuclear lamin A and C gene expression in human acute lymphoblastic leukemia and nonHodgkin's lymphoma cells. Leuk. Res. 1990, 14, 815-821.
35. Lin, F., Worman, H. J., Expression of nuclear lamins in human tissues and cancer cell lines and transcription from the promoters of the lamin A/C and B1 genes. Exp. Cell Res. 1997, 236, 378-384.
36. Solito, E., de Coupade, C., Parente, L., Flower, R. J. et al., Human annexin 1 is highly expressed during the differentiation of the epithelial cell line A 549: Involvement of nuclear factor interleukin 6 in phorbol ester induction of annexin 1. Cell Growth Differ 1998, 9, 327-336.
37. Parente, L., Solito, E., Annexin 1: More than an anti-phos-pholipase protein. Inflamm. Res. 2004, 53, 125-132.
38. 2-treated rat thymocytes by lipocortin I. Biochem. Biophys. Res. Commun. 1996, 220, 643-647.
39. Croxtall, J. D., Flower, R. J., Lipocortin 1 mediates dexamethasone-induced growth arrest of the A549 lung adenocarcinoma cell line. Proc. Natl. Acad. Sci. USA 1992, 89, 3571-3575.
40. Rhee, H. J., Kim, G. Y., Huh, J. W., Kim, S. W. et al., Annexin I is a stress protein induced by heat, oxidative stress and a sulfhydryl-reactive agent. Eur. J. Biochem. 2000, 267, 3220-3225.
41. Shen, D., Chang, H. R., Chen, Z., He, J. et al., Loss of annexin A1 expression in human breast cancer detected by multiple high-throughput analyses. Biochem. Biophys. Res. Commun. 2005, 326, 218-227.
42. Paweletz, C. P., Ornstein, D. K., Roth, M. J., Bichsel, V. E. et al., Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma. Cancer Res. 2000, 60, 6293-6297.
43. Patton, K. T., Chen, H. M., Joseph, L.,Yang, X. J., Decreased annexin I expression in prostatic adenocarcinoma and in high-grade prostatic intraepithelial neoplasia. Histopathology 2005, 47, 597-601.
44. Vishwanatha, J. K., Salazar, E., Gopalakrishnan, V. K., Absence of annexin I expression in B-cell non-Hodgkin's lymphomas and cell lines. BMC Cancer 2004, 4,8.
45. Xia, S. H., Hu, L. P., Hu, H., Ying, W. T. et al., Three isoforms of annexin I are preferentially expressed in normal esophageal epithelia but down-regulated in esophageal squamous cell carcinomas. Oncogene 2002, 27, 6641-6648.
46. Tsao, F. H., Meyer, K. C., Chen, X., Rosenthal, N. S. et al., Degradation of annexin I in bronchoalveolar lavage fluid from patients with cystic fibrosis. Am. J. Respir. Cell Mol. Biol. 1998, 78, 120-128.
47. Yee, D. S., Narula, N., Ramzy, I., Boker, J. et al., Reduced annexin II protein expression in high-grade prostatic intrae-pithelial neoplasia and prostate cancer. Arch. Pathol. Lab. Med. 2007, 737, 902-908.
48. Gillette, J. M., Chan, D. C., Nielsen-Preiss, S. M., Annexin 2 expression is reduced in human osteosarcoma metastases. J. Cell. Biochem. 2004, 92, 820-832.
49. Aitken, A., 14-3-3 proteins: A historic overview. Semin. Cancer Biol. 2006, 76, 162-172.
50. Qi, W., Liu, X., Qiao, D., Martinez, J. D., Isoform-specific expression of 14-3-3 proteins in human lung cancer tissues. Int. J. Cancer 2005, 773, 359-363.
51. Hermeking, H., 14-3-3 proteins and cancer biology. Semin. Cancer Biol. 2006, 76,161.